Back
Leap Therapeutics Vs. Ingevity Industry Stock Comparison
Sell
25
LPTX
Leap Therapeutics
Last Price:
2.55
Seasonality Move:
12.25%
Sell
15
NGVT
Ingevity
Last Price:
37.03
Seasonality Move:
10.62%
Sell
25
Leap Therapeutics (LPTX)
is a Sell
Is Leap Therapeutics a Buy, Sell or Hold?
- The current Leap Therapeutics [LPTX] share price is $2.56. The Score for LPTX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- LPTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Ingevity (NGVT)
is a Sell
Is Ingevity a Buy, Sell or Hold?
- The current Ingevity [NGVT] share price is $37.04. The Score for NGVT is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- NGVT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
LPTX Stock Price Chart
What is Leap Therapeutics's stock price today?
-
The Leap Therapeutics share price today is $2.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LPTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
LPTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 46.1 | Sell |
Chaikin Money Flow: | 37352 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.58 - 2.9) | Sell |
Bollinger Bands (100): | (2.05 - 2.73) | Buy |
NGVT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 47.28 | Sell |
Chaikin Money Flow: | 509201 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.32 - 40.1) | Sell |
Bollinger Bands (100): | (36.91 - 47.49) | Sell |
LPTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.55 | Buy |
20-day SMA: | 2.7 | Sell |
50-day SMA: | 2.59 | Sell |
200-day SMA: | 2.72 | Sell |
8-day EMA: | 2.56 | Buy |
20-day EMA: | 2.64 | Sell |
50-day EMA: | 2.6 | Sell |
200-day EMA: | 2.72 | Sell |
NGVT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.05 | Sell |
20-day SMA: | 37.78 | Sell |
50-day SMA: | 38.09 | Sell |
200-day SMA: | 44.29 | Sell |
8-day EMA: | 37.4 | Sell |
20-day EMA: | 37.93 | Sell |
50-day EMA: | 38.95 | Sell |
200-day EMA: | 43.92 | Sell |
Leap Therapeutics Earnings Growth & LPTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.53 per share, and an increase next year of $0.54 per share.
Ingevity Earnings Growth & NGVT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.69 per share, and an increase next year of $1.18 per share.
Leap Therapeutics Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ingevity Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |